Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

ESMO Immuno-Oncology Congress 2022

07 - 09 Dec 2022

Geneva, Switzerland

ESMO-Immuno-Oncology-2022-1000x1000-No-Bubbles

Resources are available according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

Abstracts and ePosters are open access. Slides and webcasts are reserved to registered Delegates and ESMO Members.

Meeting programme

From the basics of immunotherapies to the latest research results; from understanding different treatment options to the management of toxicities and interpretation of new data, the ESMO Immuno-Oncology Congress caters to the diverse needs of oncology stakeholders with an interest in this topical field of cancer treatment.

Learning objectives
  • Update your knowledge on the fast-developing field of cancer immunotherapy
  • Review state-of-the-art in novel diagnostics, biomarkers and therapeutic strategies in immune-oncology
  • Understand recent developments on immune modulation, including tumour microenvironment, immunometabolism, epigenetics or microbiome
  • Update your knowledge on novel immune-oncology strategies including immune-cells therapies, multi-specific antibodies, oncolytic virus or cancer vaccines
  • Be informed on emerging evidence and research on immunotherapies in combination with other anti-cancer targeted therapies

Industry partners' Satellite Symposia

Watch the webcasts

Hide
Filter by:
Search:
Reset

There are 360 resources available

What is the CD226 Axis?

Presenter: Solange Peters

Session: GSK - The need to advance checkpoint blockade for cancer immunotherapy and the potential role of the CD226 Axis

Resources:

Webcast

Panel discussion / Q&A

Presenter: Solange Peters

Session: GSK - The need to advance checkpoint blockade for cancer immunotherapy and the potential role of the CD226 Axis

Resources:

Webcast

T cell differentiation

Presenter: John Haanen

Session: Epigenetic immunomodelling

Resources:

Slides

Webcast

Immunotherapy plus PARP

Presenter: Anniina Färkkilä

Session: Gynaecological malignancies and breast tumours

Resources:

Slides

Webcast

Q&A

Presenter: To be Announced

Session: Epigenetic immunomodelling

Resources:

Webcast

Q&A

Presenter: George Coukos

Session: Gynaecological malignancies and breast tumours

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.